文献速递临床免疫临床生化

新型醛固酮与肾素免疫分析的分析评估及生物临床验证

Analytical evaluation and bioclinical validation of new aldosterone and renin immunoassays.
PubMed 文献 · Clin Chem Lab Med · 2022-09-13

研究评估了Lumipulse G600II系统上新型醛固酮和肾素免疫分析的分析性能,并与iSYS系统进行比较。结果显示两种分析的精密度CV分别小于3%和6%,线性优良,与iSYS系统强相关(R2=1)但存在轻微低估,且基于诊断标准得到相同临床诊断。EDTA血浆、肝素血浆和血清之间相关性良好。结论认为该分析适用于常规使用,但建议肾素标准化至WHO国际标准。

要点

  • Lumipulse G醛固酮和肾素分析的精密度CV分别小于3%和6%。
  • 与iSYS系统比较R2=1,但醛固酮和肾素存在轻微低估。
  • 两种系统基于诊断标准得出相同临床诊断,样本类型间相关性良好。

核心结论

  • Lumipulse G醛固酮和肾素分析性能适合医学实验室常规使用。
  • 低范围精确定量可能对站位/卧位试验等临床情境有价值。
  • 建议肾素针对WHO国际标准进行标准化。

研究设计与样本

  • 使用Lumipulse G醛固酮和肾素分析进行不精密度研究、线性和方法比较(n=107)。
  • 使用WHO国际标准(WHO IS 68/356)测试肾素分析的准确性。
  • 评估不同样本类型的等效性(n=29)。
  • 与iSYS系统比较(n=79)。

主要发现

  • Lumipulse G醛固酮和肾素分析的CV分别小于3%和6%。
  • 在临床范围内线性优良。
  • 与iSYS分析比较R2=1,但醛固酮偏倚为-17.53 pg/mL或48.56 pmol/L,肾素偏倚为-15.395 pg/mL。
  • 基于诊断标准的列联表研究显示Lumipulse G结果导致与iSYS结果相同的临床诊断。
  • EDTA血浆与肝素血浆以及血清在所有测量范围内均显示清晰相关性。

关键数值与推荐

  • 不精密度:Lumipulse G醛固酮CV小于3%,肾素CV小于6%。
  • 方法比较:与iSYS系统R2=1,醛固酮偏倚-17.53 pg/mL或48.56 pmol/L,肾素偏倚-15.395 pg/mL。

临床怎么用

  • 该分析可用于疑似或确诊原发性醛固酮增多症患者的常规检测。
  • 低范围精确定量可能有助于站位/卧位试验等临床情境。
  • 建议肾素标准化至WHO国际标准以确保结果可比性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aldosterone and renin determinations play an important role in the etiological diagnosis of secondary hypertension. The analytical performances of new aldosterone and renin immunoassays on the Lumipulse G600II® system (Fujierbio) were investigated and compared with those of the iSYS® system (IDS) on patients concerned by medical investigations in a context of suspected or proven Primary aldosteronism. METHODS: By using the Lumipulse® G Aldosterone and Renin assays we performed imprecision study, linearity and method comparison (n=107). Accuracy of this new renin assay was tested using the International Standard (WHO IS 68/356). We also assessed the equivalence of the different samples types (n=29). RESULTS: The imprecision evaluation showed all CVs <3% and <6% for Lumipulse® G Aldosterone and Renin assays respectively. The linearity was excellent over the clinical range and the comparison with the iSYS® assays (n=79) showed a strong correlation (R2=1) despite a slight tendency to underestimation (bias of -17.53 pg/mL or 48.56 pmol/L for aldosterone and -15.395 pg/mL for renin). Moreover, the contingency studies based on diagnostic criteria showed that Lumipulse® G results lead to the same clinical diagnosis that iSYS® results. A clear correlation was obtained between EDTA and heparin plasma as well as with the serum for all range of measures. CONCLUSIONS: The Lumipulse® G Aldosterone and Renin assays present performances compatible with a routine use in medical laboratories. The precise quantification in the low range can be of interest in some clinical contexts especially standing/laying tests. However, the standardisation against the WHO International Standard Renin would be advisable.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Coulon C, Lotierzo M, Fesler P, et al. Analytical evaluation and bioclinical validation of new aldosterone and renin immunoassays. Clin Chem Lab Med. 2022. PMID: 36096492. doi:10.1515/cclm-2022-0576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。